• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症化疗继发的粒细胞缺乏症与住院期间行中心静脉置管的患者较高的院内死亡率相关。

Agranulocytosis Secondary to Cancer Chemotherapy Associated With Higher In-Hospital Mortality in Patients With Central Line Insertion During a Hospital Stay.

作者信息

Mohamed Jiffry Mohamed Z, Khan Aimal, Carmona Pires Felipe, Okam Nkechi A, Vargas Jonathan, Moin Kayvon, Josephs Meagan

机构信息

Internal Medicine, Danbury Hospital, Danbury, USA.

Internal medicine, Danbury Hospital, Fairfield, USA.

出版信息

Cureus. 2023 Feb 7;15(2):e34717. doi: 10.7759/cureus.34717. eCollection 2023 Feb.

DOI:10.7759/cureus.34717
PMID:36909119
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9996671/
Abstract

Background Agranulocytosis secondary to cancer chemotherapy (ASCC) remains a leading cause of morbidity and mortality. Central line-associated bloodstream infections (CLABSI) are also particularly prevalent in these populations and may portend a poorer outcome. Our study serves to investigate the relationship between patients with agranulocytosis secondary to cancer chemotherapy and the insertion of a central venous catheter (CVC) with respect to in-hospital mortality. Methods and results We utilized the National Inpatient Survey 2019 database. We utilized the International Classification of Diseases (ICD)-10 CM codes to identify ASCC and other medical comorbidities. We utilized ICD-10 PCS codes to identify CVC insertions. Multivariate logistic regression was utilized to study the effect of CVC insertion on in-hospital mortality. In patients with ASCC, CVC insertion was associated with a higher in-hospital mortality (unadjusted: 11.9% vs. 1%, p<0.001, adjusted OR 19.27, 95% CI 5.84 - 65.6, p<0.001) adjusted for baseline characteristics and other comorbidities. Patients in the study cohort who were older than 70 years of age also had a higher in-hospital mortality relative to younger age groups (adjusted OR 2.31, 95% CI 1.04-5.13, p<0.039). Conclusion In patients with ASCC, CVC insertion during hospitalization is associated with higher in-hospital mortality.

摘要

背景

癌症化疗继发的粒细胞缺乏症(ASCC)仍然是发病和死亡的主要原因。中心静脉导管相关血流感染(CLABSI)在这些人群中也特别普遍,并且可能预示着更差的预后。我们的研究旨在调查癌症化疗继发粒细胞缺乏症患者与中心静脉导管(CVC)插入之间关于住院死亡率的关系。方法和结果:我们使用了2019年全国住院患者调查数据库。我们使用国际疾病分类(ICD)-10 CM编码来识别ASCC和其他医学合并症。我们使用ICD-10 PCS编码来识别CVC插入。多因素逻辑回归用于研究CVC插入对住院死亡率的影响。在ASCC患者中,调整基线特征和其他合并症后,CVC插入与较高的住院死亡率相关(未调整:11.9%对1%,p<0.001,调整后的OR为19.27,95%CI为5.84 - 65.6,p<0.001)。研究队列中年龄大于70岁的患者相对于较年轻年龄组也有较高的住院死亡率(调整后的OR为2.31,95%CI为1.04 - 5.13,p<0.039)。结论:在ASCC患者中,住院期间插入CVC与较高的住院死亡率相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da07/9996671/13284d0a0039/cureus-0015-00000034717-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da07/9996671/13284d0a0039/cureus-0015-00000034717-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da07/9996671/13284d0a0039/cureus-0015-00000034717-i01.jpg

相似文献

1
Agranulocytosis Secondary to Cancer Chemotherapy Associated With Higher In-Hospital Mortality in Patients With Central Line Insertion During a Hospital Stay.癌症化疗继发的粒细胞缺乏症与住院期间行中心静脉置管的患者较高的院内死亡率相关。
Cureus. 2023 Feb 7;15(2):e34717. doi: 10.7759/cureus.34717. eCollection 2023 Feb.
2
Venue of catheter insertion does not significantly impact the event of central line-associated bloodstream infection in patients with haematological diseases.对于血液病患者,导管插入部位对中心静脉导管相关血流感染的发生没有显著影响。
Infect Prev Pract. 2020 Mar 4;2(2):100050. doi: 10.1016/j.infpip.2020.100050. eCollection 2020 Jun.
3
The effect of the multimodal intervention including an automatic notification of catheter days on reducing central line-related bloodstream infection: a retrospective, observational, quasi-experimental study.多模态干预(包括对导管留置天数的自动通知)对降低中心静脉相关血流感染的效果:一项回顾性、观察性、准实验研究。
BMC Infect Dis. 2022 Jul 8;22(1):604. doi: 10.1186/s12879-022-07588-9.
4
The influence of intensive care unit-acquired central line-associated bloodstream infection on in-hospital mortality: A single-center risk-adjusted analysis.重症监护病房获得性中心静脉导管相关血流感染对院内死亡率的影响:一项单中心风险调整分析。
Am J Infect Control. 2016 May 1;44(5):587-92. doi: 10.1016/j.ajic.2015.12.008. Epub 2016 Feb 10.
5
Emergency Department Central Line-associated Bloodstream Infections (CLABSI) Incidence in the Era of Prevention Practices.预防措施时代急诊科中心静脉导管相关血流感染(CLABSI)的发生率
Acad Emerg Med. 2015 Sep;22(9):1048-55. doi: 10.1111/acem.12744.
6
Comparison of Rates of Central Line-Associated Bloodstream Infections in Patients With 1 vs 2 Central Venous Catheters.比较 1 根与 2 根中心静脉导管患者的中心静脉导管相关血流感染发生率。
JAMA Netw Open. 2020 Mar 2;3(3):e200396. doi: 10.1001/jamanetworkopen.2020.0396.
7
Management of enterococcal central line-associated bloodstream infections in patients with cancer.癌症患者肠球菌相关性血流感染的管理。
BMC Infect Dis. 2021 Jul 5;21(1):643. doi: 10.1186/s12879-021-06328-9.
8
Failure of central venous catheter insertion and care bundles in a high central line-associated bloodstream infection rate, high bed occupancy hospital.在高中心静脉导管相关性血流感染率、高床位占用率的医院中,中心静脉导管插入和护理包的失败。
Am J Infect Control. 2020 Jul;48(7):770-776. doi: 10.1016/j.ajic.2019.11.018. Epub 2020 Jan 3.
9
Lower risk of bloodstream infections for peripherally inserted central catheters compared to central venous catheters in critically ill patients.与中心静脉导管相比,外周静脉置入中心静脉导管在危重症患者中降低血流感染风险。
Antimicrob Resist Infect Control. 2022 Nov 9;11(1):137. doi: 10.1186/s13756-022-01180-1.
10
Peripherally inserted central catheters have a protective role and the effect of fluctuation curve feature in the risk of bloodstream infection compared with central venous catheters: a propensity-adjusted analysis.与中心静脉导管相比,外周置入中心静脉导管具有保护作用和波动曲线特征对血流感染风险的影响:倾向评分调整分析。
BMC Infect Dis. 2022 Mar 26;22(1):289. doi: 10.1186/s12879-022-07265-x.

引用本文的文献

1
Discovering patient groups in sequential electronic healthcare data using unsupervised representation learning.使用无监督表示学习在序贯电子医疗数据中发现患者群体。
BMC Med Inform Decis Mak. 2025 Jan 28;25(1):45. doi: 10.1186/s12911-024-02812-9.

本文引用的文献

1
Incidence, risk factors and healthcare costs of central line-associated nosocomial bloodstream infections in hematologic and oncologic patients.血液系统恶性肿瘤和实体瘤患者中心静脉相关血流感染的发生率、危险因素和医疗保健成本。
PLoS One. 2020 Jan 24;15(1):e0227772. doi: 10.1371/journal.pone.0227772. eCollection 2020.
2
Effects of Organizational Characteristics on Outcomes and Resource Use in Patients With Cancer Admitted to Intensive Care Units.组织特征对入住重症监护病房癌症患者结局和资源利用的影响。
J Clin Oncol. 2016 Sep 20;34(27):3315-24. doi: 10.1200/JCO.2016.66.9549. Epub 2016 Jul 18.
3
Risk factors for hospital and long-term mortality of critically ill elderly patients admitted to an intensive care unit.
入住重症监护病房的老年危重症患者的医院死亡及长期死亡风险因素。
Biomed Res Int. 2014;2014:960575. doi: 10.1155/2014/960575. Epub 2014 Dec 16.
4
Patterns of chemotherapy-associated toxicity and supportive care in US oncology practice: a nationwide prospective cohort study.美国肿瘤学实践中化疗相关毒性和支持性护理模式:一项全国性前瞻性队列研究。
Cancer Med. 2014 Apr;3(2):434-44. doi: 10.1002/cam4.200. Epub 2014 Feb 17.
5
Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: A systematic review.癌症化疗患者中性粒细胞减少性发热的危险因素:系统评价。
Crit Rev Oncol Hematol. 2014 Jun;90(3):190-9. doi: 10.1016/j.critrevonc.2013.12.006. Epub 2013 Dec 12.
6
Agreement in classifying bloodstream infections among multiple reviewers conducting surveillance.多名监测人员对血流感染进行分类时的一致性。
Clin Infect Dis. 2012 Aug;55(3):364-70. doi: 10.1093/cid/cis410. Epub 2012 Apr 26.
7
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.抗菌药物在肿瘤中性粒细胞减少患者应用的临床实践指南:美国传染病学会 2010 年更新版。
Clin Infect Dis. 2011 Feb 15;52(4):e56-93. doi: 10.1093/cid/cir073.
8
Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.预防性使用抗生素加或减粒细胞集落刺激因子预防小细胞肺癌化疗引起的发热性中性粒细胞减少:一项荷兰随机III期研究
J Clin Oncol. 2005 Nov 1;23(31):7974-84. doi: 10.1200/JCO.2004.00.7955.
9
Risk models for predicting chemotherapy-induced neutropenia.预测化疗引起的中性粒细胞减少症的风险模型。
Oncologist. 2005 Jun-Jul;10(6):427-37. doi: 10.1634/theoncologist.10-6-427.
10
Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States.美国医院血液系统恶性肿瘤和实体瘤患者医院血流感染的流行病学现状。
Clin Infect Dis. 2003 May 1;36(9):1103-10. doi: 10.1086/374339. Epub 2003 Apr 14.